Page 342 - Prevention and Treatment of Incisional Hernia- New Techniques and Materials

Chapter 17
46. Ellis H, Moran BJ, Thompson JN, Parker MC, Wilson MS, Menzies D, et al. Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet. 1999;353(9163):1476-80.
47. Leber GE, Garb JL, Alexander AI, Reed WP. Long-term complications associated with prosthetic repair of incisional hernias. Arch Surg. 1998;133(4):378-82.
48. Stanciu D, Menzies D. The magnitude of adhesion-related problems. Colorectal Dis. 2007;9 Suppl 2:35-8.
49. Sanchez VM, Abi-Haidar YE, Itani KM. Mesh infection in ventral incisional hernia repair: incidence, contributing factors, and treatment. Surg Infect (Larchmt). 2011;12(3):205-10.
50. Choi JJ, Palaniappa NC, Dallas KB, Rudich TB, Colon MJ, Divino CM. Use of mesh during ventral hernia repair in clean-contaminated and contaminated cases: outcomes of 33,832 cases. Ann Surg. 2012;255(1):176-80.
51. Engelsman AF, van der Mei HC, Ploeg RJ, Busscher HJ. The phenomenon of infection with abdominal wall reconstruction. Biomaterials. 2007;28(14):2314-27.
52. Ventral Hernia Working G, Breuing K, Butler CE, Ferzoco S, Franz M, Hultman CS, et al. Incisional ventral hernias: review of the literature and recommendations regarding the grading and technique of repair. Surgery. 2010;148(3):544-58.
53. Huerta S, Varshney A, Patel PM, Mayo HG, Livingston EH. Biological Mesh Implants for Abdominal Hernia Repair: US Food and Drug Administration Approval Process and Systematic Review of Its E cacy. JAMA Surg. 2016;151(4):374-81.
54. Itani KM, Rosen M, Vargo D, Awad SS, Denoto G, 3rd, Butler CE, et al. Prospective study of single- stage repair of contaminated hernias using a biologic porcine tissue matrix: the RICH Study. Surgery. 2012;152(3):498-505.
55. Miserez M, Grass G, Weiss C, Stutzer H, Sauerland S, Neugebauer EA, et al. Closure of the LAPSIS trial. Br J Surg. 2010;97(10):1598.
56. Rosen MJ, Denoto G, Itani KM, Butler C, Vargo D, Smiell J, et al. Evaluation of surgical outcomes of retro-rectus versus intraperitoneal reinforcement with bio-prosthetic mesh in the repair of contaminated ventral hernias. Hernia. 2013;17(1):31-5.
57. Rosen MJ, Krpata DM, Ermlich B, Blatnik JA. A 5-year clinical experience with single-staged repairs of infected and contaminated abdominal wall defects utilizing biologic mesh. Ann Surg. 2013;257(6):991-6.
58. Majumder A, Winder JS, Wen Y, Pauli EM, Belyansky I, Novitsky YW. Comparative analysis of biologic versus synthetic mesh outcomes in contaminated hernia repairs. Surgery. 2016;160(4):828-38.
59. Madani A, Niculiseanu P, Marini W, Kaneva PA, Mappin-Kasirer B, Vassiliou MC, et al. Biologic
mesh for repair of ventral hernias in contaminated elds: long-term clinical and patient-reported
outcomes. Surg Endosc. 2016.
60. Deeken CR, Melman L, Jenkins ED, Greco SC, Frisella MM, Matthews BD. Histologic and
biomechanical evaluation of crosslinked and non-crosslinked biologic meshes in a porcine model
of ventral incisional hernia repair. J Am Coll Surg. 2011;212(5):880-8.
61. Pascual G, Sotomayor S, Rodriguez M, Arteaga V, Bellon JM. Extraperitoneal and intraperitoneal
behavior of several biological meshes currently used to repair abdominal wall defects. Journal of
biomedical materials research Part B, Applied biomaterials. 2015;103(2):365-72.
62. Cornwell KG, Landsman A, James KS. Extracellular matrix biomaterials for soft tissue repair. Clin
Podiatr Med Surg. 2009;26(4):507-23.
63. Badylak SF. The extracellular matrix as a biologic sca old material. Biomaterials. 2007;28(25):3587-
93.
64. Chavarriaga LF, Lin E, Losken A, Cook MW, Jeansonne LO, White BC, et al. Management of complex
abdominal wall defects using acellular porcine dermal collagen. Am Surg. 2010;76(1):96-100.
65. Harth KC, Rosen MJ. Major complications associated with xenograft biologic mesh implantation in
abdominal wall reconstruction. Surg Innov. 2009;16(4):324-9.
66. Helton WS, Fisichella PM, Berger R, Horgan S, Espat NJ, Abcarian H. Short-term outcomes with small
intestinal submucosa for ventral abdominal hernia. Arch Surg. 2005;140(6):549-60; discussion 60-2.
67. Shah BC, Tiwari MM, Goede MR, Eichler MJ, Hollins RR, McBride CL, et al. Not all biologics are equal!
Hernia. 2011;15(2):165-71.
68. Ueno T, Pickett LC, de la Fuente SG, Lawson DC, Pappas TN. Clinical application of porcine small
intestinal submucosa in the management of infected or potentially contaminated abdominal defects. J Gastrointest Surg. 2004;8(1):109-12.
340